High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

BACKGROUND: The optimal induction treatment in potentially-resectable stage IIIA-N2 NSCLC remains undefined. AIM: To compare neoadjuvant high-dose chemoradiotherapy (CRT) to neoadjuvant chemotherapy (CHT) in patients with resectable, stage IIIA-N2 non-small-cell lung cancer (NSCLC). METHODS: Retrosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Rep Pract Oncol Radiother
Autors principals: Montemuiño, Sara, Dios, Núria Rodriguez de, Martín, Margarita, Taboada, Begoña, Calvo-Crespo, Patricia, Samper-Ots, María Pilar, López-Guerra, José Luis, López-Mata, M., Jové-Teixidó, Josep, Díaz-Díaz, Verónica, Ingunza-Barón, Lourdes de, Murcia-Mejía, Mauricio, Chust, Marisa, García-Cañibano, Tamara, Couselo, María Luz, Puertas, María Mar, Cerro, Elia del, Moradiellos, Javier, Amor, Sergio, Varela, A., Thuissard, I.J., Sanz-Rosa, David, Couñago, Felipe
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original research article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244888/
https://ncbi.nlm.nih.gov/pubmed/32477011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rpor.2020.03.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars